Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3368)
All Articles published online
|
Sep 14, 2007 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Diao Y, Ma J, Xiao WD, Luo J, Li XY, Chu KW, Fung PW, Habib N, Farzaneh F, Xu RA. Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistatin. World J Gastroenterol 2007; 13(34): 4615-4619 [PMID: 17729417 DOI: 10.3748/wjg.v13.i34.4615] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i34/4615.htm |
| Number | Citing Articles |
| 1 |
Xian Jiang, Hali Li, Haiquan Qiao, Hongchi Jiang, Ruian Xu, Xueying Sun. Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Science 2009; 100(11): 2226 doi: 10.1111/j.1349-7006.2009.01306.x
|
| 2 |
Julie Chao, Pengfei Li, Lee Chao. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. Biological Chemistry 2017; 398(12): 1309 doi: 10.1515/hsz-2017-0180
|
| 3 |
Behzad Shahbazi, Ladan Mafakher, Seyed Shahriar Arab, Ladan Teimoori-Toolabi. Kallistatin as an inhibitory protein against colorectal cancer cells through binding to LRP6. Journal of Biomolecular Structure and Dynamics 2024; 42(2): 918 doi: 10.1080/07391102.2023.2196704
|
| 4 |
Guoquan Wang, Xiao Wang, Xiaoping Huang, Huiyong Yang, Suqiu Pang, Xiaolan Xie, Shulan Zeng, Junsheng Lin, Yong Diao. Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells. Cancer Cell International 2016; 16(1) doi: 10.1186/s12935-016-0365-7
|
| 5 |
Nam-Hui Yim, Won-Kyung Cho, Ju Hye Lee, Young Pil Jung, Hye Jin Yang, Jin Yeul Ma. HRT, Herbal Formula, Induces G2/M Cell Cycle Arrest and Apoptosis via Suppressing Akt Signaling Pathway in Human Colon Cancer Cells. Evidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/871893
|
| 6 |
Mahboobe Ghaedi, Masoud Soleimani, Narges Mohammad Taghvaie, Mahmood Sheikhfatollahi, Keyhan Azadmanesh, Abbas S. Lotfi, Jian Wu. Mesenchymal stem cells as vehicles for targeted delivery of anti‐angiogenic protein to solid tumors. The Journal of Gene Medicine 2011; 13(3): 171 doi: 10.1002/jgm.1552
|
| 7 |
Julie Chao, Grant Bledsoe, Lee Chao. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension 2016; 68(3): 533 doi: 10.1161/HYPERTENSIONAHA.116.07861
|
| 8 |
Caiqi Ma, Chuanghua Luo, Haofan Yin, Yang Zhang, Wenjun Xiong, Ting Zhang, Tianxiao Gao, Xi Wang, Di Che, Zhenzhen Fang, Lei Li, Jinye Xie, Mao Huang, Liuqing Zhu, Ping Jiang, Weiwei Qi, Ti Zhou, Zhonghan Yang, Wei Wang, Jianxing Ma, Guoquan Gao, Xia Yang. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion. Gastric Cancer 2018; 21(4): 617 doi: 10.1007/s10120-017-0787-5
|
| 9 |
Xiaoping Huang, Xiao Wang, Yinghui Lv, Luli Xu, Junsheng Lin, Yong Diao, David L. McCormick. Protection Effect of Kallistatin on Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Antioxidative Stress. PLoS ONE 2014; 9(2): e88498 doi: 10.1371/journal.pone.0088498
|
| 10 |
Wai Han Yiu, Dickson W.L. Wong, Hao Jia Wu, Rui Xi Li, Irene Yam, Loretta Y.Y. Chan, Joseph C.K. Leung, Hui Yao Lan, Kar Neng Lai, Sydney C.W. Tang. Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress. Kidney International 2016; 89(2): 386 doi: 10.1038/ki.2015.331
|
| 11 |
Jake S. Burrell, Simon Walker‐Samuel, Lauren C. J. Baker, Jessica K. R. Boult, Anderson J. Ryan, John C. Waterton, Jane Halliday, Simon P. Robinson. Investigating temporal fluctuations in tumor vasculature with combined carbogen and ultrasmall superparamagnetic iron oxide particle (CUSPIO) imaging. Magnetic Resonance in Medicine 2011; 66(1): 227 doi: 10.1002/mrm.22779
|
| 12 |
Caiqi Ma, Haofan Yin, Jun Zhong, Yang Zhang, Chuanghua Luo, Di Che, Zhenzhen Fang, Lei Li, Shuxing Qin, Jieying Liang, Weiwei Qi, Zhonghan Yang, Ti Zhou, Jianxing Ma, Xia Yang, Guoquan Gao. Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation. International Journal of Oncology 2017; 50(6): 2000 doi: 10.3892/ijo.2017.3972
|
| 13 |
Yanhui Yang, Xuemin He, Rui Cheng, Qian Chen, Chunyan Shan, Liming Chen, Jian‐xing Ma. Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation. The FASEB Journal 2020; 34(6): 8428 doi: 10.1096/fj.201903149R
|
| 14 |
Emmanuel Giannas, Christos Kontovounisios. The Antineoplastic Effect of Heparin on Colorectal Cancer: A Review of the Literature. Journal of Clinical Medicine 2023; 12(22): 7173 doi: 10.3390/jcm12227173
|
| 15 |
Weihong Qu, Mingxi Wang, Yaqing Wu, Yinghui Lv, Qizhao Wang, Ruian Xu. Calcium-ion-modulated ceramic hydroxyapatite resin for the scalable purification of recombinant Adeno-Associated Virus serotype 9. Journal of Chromatography B 2015; 990: 15 doi: 10.1016/j.jchromb.2015.03.003
|
| 16 |
Xiao-Ping Huang, Xiao Wang, Xiao-Lan Xie, Gao-Ping Zhang, Feng-Jiao Lv, Wen-Ting Weng, Fei Qiu, Zhao-Fa Li, Jun-Sheng Lin, Yong Diao. Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin. Oncotarget 2018; 9(2): 2220 doi: 10.18632/oncotarget.23346
|
| 17 |
Julie Chao, Pengfei Li, Lee Chao. Kallistatin suppresses cancer development by multi-factorial actions. Critical Reviews in Oncology/Hematology 2017; 113: 71 doi: 10.1016/j.critrevonc.2017.03.011
|